Bocxman: I agree that a PMA would be best. Better to have good solid data to support you than to just have "preliminary results". I also agree that publication in a peer-reviewed journal is a good thing, but the sooner we get exposure in something like Science, JAMA[/], or The New England Journal of Medicine the better. I think this will happen when we finally have the results of a larger study. Perhaps this will be done by Abbott or Goshen. We need a name journal with a high impact factor.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.